Beyond fraud - Stem-cell research continues

New England Journal of Medicine

Volumn 354, Issue 4, 2006, Pages 321-324

  Snyder, Evan Y ^a   Loring, Jeanne F ^a  

^a BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMEDICINE; CELL NUCLEUS; CYTOLOGY; ETHICS; GENETICS; GOVERNMENT; HUMAN; LABORATORY; LAW; MEDICAL LITERATURE; MEDICAL RESEARCH; NONHUMAN; OOCYTE DONATION; PRIORITY JOURNAL; REVIEW; SCIENCE; STEM CELL;

BIOMEDICAL AND BEHAVIORAL RESEARCH; GENETICS AND REPRODUCTION;

CELL LINE; CLONING, ORGANISM; EMBRYO; EMBRYO RESEARCH; HUMANS; KOREA; NUCLEAR TRANSFER TECHNIQUES; RESEARCH EMBRYO CREATION; SCIENTIFIC MISCONDUCT; STEM CELLS;

EID: 31344445922     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMp058323     Document Type: Review

References (5)

1. Hwang WS, Ryu YJ, Park JH, et al. Evidence of a pluripotent embryonic stem cell line derived from a cloned blastocyst. Science 2004;303:1669-74.
2. Hwang WS, Roh SI, Lee BC, et al. Patient-specific embryonic stem cells derived from human SCNT blastocysts. Science 2005;308: 1777-83.
3. Committee on Guidelines for Human Embryonic Stem Cell Research, National Research Council. Guidelines for human embryonic stem cell research. Washington, D.C.: National Academies Press, 2005.
4. Meissner A, Jaenisch R. Generation of nuclear transfer-derived pluripotent ES cells from cloned Cdx2-deficient blastocysts. Nature. October 16, 2005 (Web only). (Accessed January 10, 2006, at http://www. nature.com/nature/journal/vaop/ncurrent/ full/nature04257.html.)
5. Drukker M, Katchman H, Katz G, et al. Human embryonic stem cells and their differentiated derivatives are less susceptible for immune rejection than adult cells. Stem cells (in press).